Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
============================================================================================

* Michael M. Boyiadzis
* John M. Kirkwood
* John L. Marshall
* Colin C. Pritchard
* Nilofer S. Azad
* James L. Gulley